Summary
Design and development plans establish your systematic approach to transforming user needs into compliant medical devices. These plans define the framework for both software and hardware development, ensuring traceability, risk management, and regulatory compliance throughout your product lifecycle while preventing costly rework and documentation gaps.Regulatory Context
- FDA
- MDR
Under 21 CFR Part 820.30 (Design Controls), the FDA requires:
- Documented development planning describing design activities and responsibilities
- Software lifecycle processes following IEC 62304 consensus standard
- Hardware development approach with systematic materials selection and verification
- Risk management integration throughout development phases
- Design History File (DHF) documentation for all activities
- IEC 62304:2006 - Medical device software lifecycle processes
- ISO 14971:2019 - Application of risk management to medical devices
- ISO 13485:2016 - Medical devices quality management systems
- IEC 60601-1 - Medical electrical equipment safety (if applicable)
Special attention required for:
- Software safety classification accuracy - misclassification leads to inadequate development rigor
- SOUP vulnerability management and ongoing monitoring for software components
- Biocompatibility testing requirements for hardware materials in patient contact
- Cybersecurity considerations per FDA guidance for connected devices